• LAST PRICE
    19.7900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    19.2500/ 2
  • Ask / Lots
    21.0000/ 4
  • Open / Previous Close
    --- / 19.7900
  • Day Range
    ---
  • 52 Week Range
    Low 6.7600
    High 30.0000
  • Volume
    151
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 18.2
TimeVolumeALGS
09:32 ET292418.2399
09:33 ET646918
09:35 ET364118.1063
09:37 ET309818.2299
09:39 ET285417.9842
09:42 ET147018.0211
09:44 ET282017.76
09:46 ET331517.79
09:48 ET290117.9
09:50 ET55017.9
09:51 ET192017.81
09:53 ET192917.7
09:55 ET90017.5811
09:57 ET431417.75
10:00 ET2054817.83
10:02 ET659717.87
10:04 ET248618.08
10:06 ET608018.075
10:08 ET407218
10:09 ET561518.0015
10:11 ET109518.15
10:13 ET288718.2
10:15 ET20018.12
10:18 ET190018.1869
10:20 ET237718.2
10:24 ET35018.3971
10:27 ET60018.26
10:29 ET90018.21
10:31 ET47518.1501
10:33 ET38018.199
10:36 ET142018
10:38 ET110018.08
10:40 ET22818.252
10:44 ET30018.02
10:45 ET297817.97
10:47 ET10018.083
10:49 ET10018.05
10:51 ET71718.014
10:54 ET138817.9
10:56 ET11117.9
11:00 ET148618.1133
11:05 ET520018.14
11:07 ET20018.17
11:09 ET10018.0591
11:14 ET225018
11:18 ET341917.88
11:20 ET49417.88
11:21 ET390917.775
11:23 ET436617.8
11:25 ET13317.6265
11:27 ET162517.7181
11:30 ET10017.87
11:32 ET10017.63
11:34 ET911117.41
11:36 ET2216917.36
11:38 ET115017.655
11:39 ET200017.6231
11:43 ET481217.725
11:48 ET60017.7292
11:50 ET20017.67
11:52 ET40017.67
11:54 ET607717.6035
11:56 ET65017.81
11:59 ET55617.89
12:01 ET20017.8872
12:03 ET20017.9
12:06 ET40017.69
12:08 ET30017.6
12:12 ET20017.7024
12:14 ET22017.79
12:15 ET20017.74
12:17 ET360617.82
12:19 ET10017.855
12:21 ET216418.125
12:24 ET100018.075
12:26 ET33018.2
12:28 ET10018.017
12:30 ET38018.094
12:32 ET10018.12
12:33 ET70418.1
12:35 ET10018.1
12:39 ET15318.075
12:44 ET12018
12:46 ET40018.1
12:50 ET62618.105
12:51 ET264618.0641
12:57 ET67018.1
01:00 ET55517.95
01:06 ET10017.95
01:09 ET100017.92
01:13 ET96118
01:15 ET50018
01:20 ET32917.95
01:22 ET10018.025
01:24 ET125018.15
01:26 ET43918.2
01:27 ET562518.41
01:29 ET921418.205
01:31 ET30018.205
01:33 ET30018.15
01:40 ET20018.205
01:42 ET54918.36
01:44 ET1937518.49
01:45 ET451118.87
01:47 ET1014319.1
01:49 ET1219419.1
01:51 ET302618.9654
01:56 ET110018.84
01:58 ET310019.0725
02:00 ET1670819.24
02:02 ET1198419.3697
02:03 ET720019.3
02:05 ET130019.19
02:07 ET588719.145
02:09 ET420519.075
02:12 ET595019.2
02:14 ET50019.05
02:16 ET730918.886
02:18 ET105318.9391
02:20 ET20018.9167
02:21 ET570019.0399
02:23 ET196218.9124
02:25 ET40018.6701
02:27 ET442118.73
02:30 ET568918.7587
02:32 ET20019.0273
02:34 ET45018.8746
02:36 ET20018.9931
02:38 ET101718.88
02:39 ET340018.9888
02:41 ET751519.1914
02:43 ET276419.213287
02:45 ET643619.43
02:48 ET1969319.3
02:50 ET369819.2
02:52 ET723519.36
02:54 ET399119.2
02:56 ET214919.2
02:57 ET95019.25
02:59 ET23519.07
03:01 ET206719.26
03:03 ET65019.22
03:06 ET596219.2
03:08 ET109719.08
03:10 ET64419.2148
03:12 ET20019.18
03:14 ET83119.08
03:15 ET15019.239
03:17 ET40019.04
03:19 ET177619.15
03:21 ET123619.43
03:24 ET331319.335
03:26 ET1836419.545
03:28 ET458619.5937
03:30 ET377219.66
03:32 ET405519.68
03:33 ET472819.7464
03:35 ET562019.83
03:37 ET1411519.9599
03:39 ET745519.77
03:42 ET294019.6
03:44 ET654119.5
03:46 ET723319.42
03:48 ET300019.5
03:50 ET646619.74
03:51 ET486719.62
03:53 ET385719.75
03:55 ET491719.8
03:57 ET661619.85
04:00 ET1232119.79
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALGS
Aligos Therapeutics Inc
71.0M
-1.1x
---
United StatesHOWL
Werewolf Therapeutics Inc
79.3M
-1.2x
---
United StatesCARM
Carisma Therapeutics Inc
35.4M
-0.5x
---
United StatesADAG
Adagene Inc
100.1M
-3.1x
---
United StatesCLSD
Clearside Biomedical Inc
77.4M
-2.3x
---
United StatesCLGN
Collplant Biotechnologies Ltd
47.7M
-2.7x
---
As of 2024-11-22

Company Information

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. The Company discovers and develops therapeutics for metabolic dysfunction associated steatohepatitis (MASH) and viruses with high unmet medical need, such as chronic hepatitis B (CHB) and coronaviruses. Its advanced drug candidate for MASH is ALG-055009, a small molecule thyroid hormone receptor beta (THR-ß) agonist. It is also progressing oligonucleotide projects for MASH. It is developing a portfolio of differentiated CHB drug candidates, including a small molecule Capsid Assembly Modulator that results in the production of empty viral capsids (CAM-E) and small molecule inhibitors of the Programmed Cell Death Ligand 1 (PD-1/PD-L1) interaction. Its third area of focus is to develop drug candidates with pan-coronavirus antiviral activity. Its pipeline includes ALG-055009, ALG-000184, ALG-125755, and ALG-097558.

Contact Information

Headquarters
One Corporate Dr., 2nd Floor, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
Phone
302-658-7581
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Lawrence Blatt
Chief Financial Officer, Executive Vice President
Lesley Calhoun
Executive Vice President, Chief Scientific Officer
Julian Symons
Executive Vice President
Matthew Mcclure
Chief Medical Officer
Hardean Achneck

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$71.0M
Revenue (TTM)
$6.0M
Shares Outstanding
3.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.39
EPS
$-18.70
Book Value
$15.36
P/E Ratio
-1.1x
Price/Sales (TTM)
11.8
Price/Cash Flow (TTM)
---
Operating Margin
-1,577.26%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.